Abstract

Introduction: Human papillomavirus (HPV) infection is the most common sexually transmitted infection worldwide. Completion of the HPV vaccine series is important in the primary prevention of cervical cancer. HPV vaccination rates remain significantly lower than those for other vaccines recommended for children ages 11–12 years. In 2016, only 43.4% of adolescents in the United States were up to date with the HPV vaccination series, whereas the rates for the tetanus, diphtheria, and acellular pertussis vaccine (Tdap) and the meningococcal conjugate vaccine were in the 80-90% range.1 Our study aims to evaluate multi-component interventions focusing on provider and …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.